Koneksa Health

New York, NY · United States

Digital Health & DTxmid

Specialization: Digital biomarkers and remote monitoring for trials

Key Differentiator

Builds digital biomarkers from remote data, such as its Parkinson's study that Merck and Regeneron joined through a data syndication program.

Core Services

Digital endpoints; Remote clinical trial data collection; Data science and AI services; SaaS platform licensing

Capabilities

Digital endpoint developmentRemote multimodal data collectionAI and ML analyticsTrial design supportRegulatory submission software (Lodestar)

Market Intelligence

Founded in 2013. Investors listed on its site include Takeda Ventures, Novartis, Merck and McKesson Ventures.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.